TCRT · Alaunos Therapeutics, Inc. · Analyst Estimates
$1.49
-0.02 (-1.32%)
At close · Sep 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the current cash forecast and the Company's dependence on its ability to obtain additional financing to fund its operations after the current resources are exhausted, about which there can be no certainty, management has determined that the Company's present capital resources will not be sufficient to fund its planned operations for at least one year from the issuance date of the financial statements which raises substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.84M
Shares
2.54M
Analyst Estimates
Compare analyst forecasts for Alaunos Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Source collection is delayed; the retained verified snapshot may not include newer publications.
Consensus not yet available
Source collection is delayed; the retained verified snapshot may not include newer publications.